NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023

Stock Information for Nanostring Technologies Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nanostring Technologies Inc

NanoString Announces Completion of Financing to Support Restructuring Process
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
NanoString Comments on Delaware District Court Verdict
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.